Target intelligence / Profile preview

Joint vasculature and subchondral bone

Molecular classification
Other
01

Overview

The joint vasculature and subchondral bone represent a critical anatomical and functional unit involved in the maintenance of joint health and the progression of degenerative diseases like osteoarthritis (OA). The subchondral bone provides essential mechanical support to the overlying articular cartilage, while its associated vasculature facilitates the exchange of nutrients and signaling molecules between the systemic circulation and the joint environment (Hu et al., 2021, Nature Reviews Rheumatology). In pathological states, increased vascular invasion and nerve growth from the subchondral bone into the calcified cartilage contribute significantly to structural instability and chronic pain (Mapp & Walsh, 2012, Nature Reviews Rheumatology). While not a single molecular target, this tissue complex is the site of action for various therapies, such as bisphosphonates that inhibit bone resorption and anti-NGF agents that target pain-related neurovascular ingrowth (Castaneda et al., 2012, Therapeutic Advances in Musculoskeletal Disease). Understanding the interplay between vascular expansion and bone remodeling in this region is essential for developing effective disease-modifying osteoarthritis drugs (DMOADs).

Other names
Osteochondral unitSubchondral bone-cartilage interfaceJoint vascular-bone nicheSubchondral bone plate
02

Mechanism of action

Modulation of bone turnover through osteoclast inhibition, suppression of pathological angiogenesis via VEGF neutralization, and inhibition of neurovascular ingrowth through NGF blockade.

03

Biological functions

Bone remodelingAngiogenesisMechanical supportNutrient transportNeurovascular crosstalk
04

Disease associations

OsteoarthritisRheumatoid arthritisOsteonecrosisSubchondral bone marrow edema
05

Safety considerations

Osteonecrosis of the jaw (ONJ)Atypical femoral fractures (AFF)Rapidly progressive osteoarthritis (RPOA)Impaired wound healing
06

Interacting drugs

Zoledronic acid

4 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type II collagen (CTX-II)Procollagen type I N-terminal propeptide (P1NP)Bone marrow lesions (BMLs) on MRI

Beyond the preview

Go deeper on Joint vasculature and subchondral bone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joint vasculature and subchondral bone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call